Climb Bio Inc (CLYM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $608.53M
Last updated: Nov 17, 2026 at 11:04 AM ET
Climb Bio Inc (CLYM) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Climb Bio reported EPS of -$0.18, above the -$0.20 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CLYM's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 19 quarters below that had an estimate, CLYM beat 10, missed 8 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 298.41% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.18 | -$0.20 | -$0.23 - -$0.16 | +10.00% | Beat | N/A | 10 | 1 up, 0 down | Nov 5, 2026 |
| Jun 30, 2026 | -$0.18 | -$0.22 | -$0.27 - -$0.18 | +18.18% | Beat | N/A | 8 | N/A | Aug 6, 2026 |
| Mar 31, 2026 | -$0.20 | -$0.30 | -$0.57 - -$0.25 | +33.33% | Beat | N/A | 8 | 0 up, 2 down | May 7, 2026 |
| Dec 31, 2025 | -$0.26 | -$0.19 | -$0.23 - -$0.19 | -38.89% | Miss | -750.0% | 3 | 0 up, 0 down | Mar 5, 2026 |
| Sep 30, 2025 | -$0.19 | -$0.15 | -$0.15 - -$0.14 | -26.67% | Miss | N/A | 2 | 0 up, 0 down | Nov 6, 2025 |
| Jun 30, 2025 | -$0.13 | -$0.18 | N/A | +27.78% | Beat | N/A | N/A | 0 up, 0 down | Aug 12, 2025 |
| Mar 31, 2025 | -$0.31 | -$0.15 | N/A | -106.67% | Miss | N/A | N/A | N/A | May 14, 2025 |
| Dec 31, 2024 | $0.04 | -$0.15 | N/A | +126.67% | Beat | N/A | N/A | N/A | Mar 25, 2025 |
| Sep 30, 2024 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2024 |
| Jun 30, 2024 | -$1.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2024 |
| Mar 31, 2024 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2024 |
| Dec 31, 2023 | -$0.13 | -$0.13 | N/A | -1.08% | Miss | N/A | N/A | N/A | Mar 4, 2024 |
| Sep 30, 2023 | -$0.15 | -$0.14 | N/A | -4.71% | Miss | N/A | N/A | N/A | Nov 6, 2023 |
| Jun 30, 2023 | -$0.19 | -$0.16 | N/A | -21.56% | Miss | N/A | N/A | N/A | Sep 11, 2023 |
| Mar 31, 2023 | -$0.84 | -$0.25 | N/A | -236.00% | Miss | N/A | N/A | N/A | May 11, 2023 |
| Dec 31, 2022 | -$0.29 | -$0.33 | N/A | +12.12% | Beat | -123.2% | N/A | N/A | Mar 31, 2023 |
| Sep 30, 2022 | -$0.37 | -$0.43 | N/A | +13.95% | Beat | N/A | N/A | N/A | Nov 14, 2022 |
| Jun 30, 2022 | -$0.56 | -$0.47 | N/A | -19.15% | Miss | N/A | N/A | N/A | Aug 15, 2022 |
| Mar 31, 2022 | -$0.50 | -$0.50 | N/A | 0.00% | In line | N/A | N/A | N/A | May 16, 2022 |
| Dec 31, 2021 | $1.25 | -$0.63 | N/A | +298.41% | Beat | N/A | N/A | N/A | Mar 31, 2022 |
| Sep 30, 2021 | -$0.70 | -$0.85 | N/A | +17.65% | Beat | N/A | N/A | N/A | Nov 8, 2021 |
| Jun 30, 2021 | -$0.61 | -$2.37 | N/A | +74.26% | Beat | N/A | N/A | N/A | Jul 16, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.89, after -$1.96 the year before. It was -$0.06 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.89 | N/A |
| Dec 31, 2024 | -$1.96 | N/A |
| Dec 31, 2023 | -$1.31 | N/A |
| Dec 31, 2022 | -$1.72 | N/A |
| Dec 31, 2021 | -$0.06 | N/A |
Frequently Asked Questions About CLYM
Did CLYM beat earnings estimates last quarter?
Yes. Climb Bio reported EPS of -$0.18 for the quarter ended Sep 30, 2026, above the -$0.20 estimate, a 10.00% surprise.
What EPS do analysts expect from CLYM next quarter?
The consensus EPS estimate for Climb Bio for the quarter ending Dec 31, 2026 is -$0.21 from 18 analysts, with estimates from -$0.25 to -$0.19.
How often does CLYM beat earnings estimates?
Climb Bio beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +5.47%.
CLYM pages: Overview, Earnings, Forecast, Financials, Competitors